Browse by:

Oxford firm spends $13M on two Marlborough properties

Zachary Comeau |

Two office buildings in Marlborough, including the U.S. home of ReWalk Robotics, have been sold to Oxford-based Minardi Limited Partnership for more than $13 million as the property management firm...

Southborough office building sold for $1M

A 4,000-square-foot office building in Southborough has been sold to a property management firm for $1 million.

Milford SaaS firm lands $8M investment

Milford-based network software company Connected2Fiber has raised $8 million in series A funding after just two years of doing business, the company announced last week.

Founder of Boost Fitness is creating a fitness empire

Brad Kane |

About 12 years ago, Mark Federico opened the first Anytime Fitness franchise in Marlborough before deciding to create his own independent business in Boost Fitness.

Noncompetes should protect IP, not trap employees

Getting new employees up to speed, from the time of hiring to when they are productive members of your team takes time and money.

Movers & Shakers

A summary of notable hires and promotions at Central Mass. companies, including Girls Inc., Central One Federal Credit Union and YOU, Inc.

101: Negotiations


They happen in boardrooms, hallways, lawyers' offices and in car dealerships. They are, of course, negotiations – seen by many as a means to an end to wrap up a transaction of some sort,...

Two of the grocery industry's unique brands are about to settle in Central Massachusetts

Grant Welker |

Grocery shopping can be a mundane experience, a get-in-and-get-out exercise not exactly stirring up passion.Then there's Whole Foods Market and Market Basket.

A new era for Aubuchon after outsourcing distribution

Emily Micucci |

In August, Aubuchon Hardware announced it would cease distribution operations in Westminster, a decision that CEO William Aubuchon, IV admitted was a tough one.

Boston Scientific's new opioid alternative

Zachary Comeau |

Boston Scientific announced Jan. 11 it received regulatory approval for a new treatment for chronic pain without the use of opioids.

Copyright 2017 New England Business Media